Financhill
Sell
50

OGI.TO Quote, Financials, Valuation and Earnings

Last price:
$2.32
Seasonality move :
19.81%
Day range:
$2.31 - $2.46
52-week range:
$1.22 - $3.09
Dividend yield:
0%
P/E ratio:
129.47x
P/S ratio:
1.15x
P/B ratio:
0.89x
Volume:
195K
Avg. volume:
418.2K
1-year change:
-0.43%
Market cap:
$311.9M
Revenue:
$259.2M
EPS (TTM):
-$0.21

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
OGI.TO
Organigram Global, Inc.
$73M -$0.01 71.72% -80% $3.40
ACB.TO
Aurora Cannabis, Inc.
$86.5M -$0.03 4.79% -91.67% $7.80
CRON.TO
Cronos Group, Inc.
$51.3M -$0.07 33.92% -156.68% $3.95
TSND.TO
Terrascend Corp.
$92M -$0.03 -12.43% -74.49% $1.74
WEED.TO
Canopy Growth Corp.
$71.8M -$0.11 -5.09% -95.48% $3.76
XLY.TO
Auxly Cannabis Group, Inc.
$35.9M -- 18.12% -- $0.2500
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
OGI.TO
Organigram Global, Inc.
$2.32 $3.40 $311.9M 129.47x $0.00 0% 1.15x
ACB.TO
Aurora Cannabis, Inc.
$5.90 $7.80 $333.8M 116.20x $0.00 0% 0.90x
CRON.TO
Cronos Group, Inc.
$3.64 $3.95 $1.4B 27.70x $0.00 0% 7.57x
TSND.TO
Terrascend Corp.
$0.97 $1.74 $296.3M -- $0.00 0% 0.75x
WEED.TO
Canopy Growth Corp.
$1.65 $3.76 $564.6M -- $0.00 0% 1.08x
XLY.TO
Auxly Cannabis Group, Inc.
$0.1400 $0.2500 $188.8M 4.59x $0.00 0% 1.40x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
OGI.TO
Organigram Global, Inc.
2.45% 2.654 2.31% 1.21x
ACB.TO
Aurora Cannabis, Inc.
15.87% 1.055 19.86% 1.52x
CRON.TO
Cronos Group, Inc.
0.16% 1.773 0.16% 20.73x
TSND.TO
Terrascend Corp.
73.06% 5.012 98.87% 0.71x
WEED.TO
Canopy Growth Corp.
26.05% 4.059 38.43% 4.06x
XLY.TO
Auxly Cannabis Group, Inc.
27.67% -1.082 33.75% 1.03x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
OGI.TO
Organigram Global, Inc.
$416K -$28M -6.89% -7.06% -35.03% -$554K
ACB.TO
Aurora Cannabis, Inc.
-$8M -$56M -9.13% -10.69% -61.96% -$46.7M
CRON.TO
Cronos Group, Inc.
$24.8M -$6.9M 3.71% 3.71% -13.83% $12.4M
TSND.TO
Terrascend Corp.
$44.7M $15.3M -14.74% -38.6% 17.11% $620.3K
WEED.TO
Canopy Growth Corp.
$16.9M -$16.4M -39.84% -68.7% -24.59% -$19.4M
XLY.TO
Auxly Cannabis Group, Inc.
$8.8M -$4.1M 22.71% 34.07% -10.27% $8.3M

Organigram Global, Inc. vs. Competitors

  • Which has Higher Returns OGI.TO or ACB.TO?

    Aurora Cannabis, Inc. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of -58.83%. Organigram Global, Inc.'s return on equity of -7.06% beat Aurora Cannabis, Inc.'s return on equity of -10.69%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    0.52% -$0.28 $357.9M
    ACB.TO
    Aurora Cannabis, Inc.
    -8.86% -$0.91 $667.4M
  • What do Analysts Say About OGI.TO or ACB.TO?

    Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 46.55%. On the other hand Aurora Cannabis, Inc. has an analysts' consensus of $7.80 which suggests that it could grow by 32.2%. Given that Organigram Global, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Organigram Global, Inc. is more attractive than Aurora Cannabis, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    ACB.TO
    Aurora Cannabis, Inc.
    2 2 0
  • Is OGI.TO or ACB.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Aurora Cannabis, Inc. has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.781%.

  • Which is a Better Dividend Stock OGI.TO or ACB.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Cannabis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Aurora Cannabis, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or ACB.TO?

    Organigram Global, Inc. quarterly revenues are $80.1M, which are smaller than Aurora Cannabis, Inc. quarterly revenues of $90.4M. Organigram Global, Inc.'s net income of -$38M is higher than Aurora Cannabis, Inc.'s net income of -$53.2M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Aurora Cannabis, Inc.'s PE ratio is 116.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.15x versus 0.90x for Aurora Cannabis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.15x 129.47x $80.1M -$38M
    ACB.TO
    Aurora Cannabis, Inc.
    0.90x 116.20x $90.4M -$53.2M
  • Which has Higher Returns OGI.TO or CRON.TO?

    Cronos Group, Inc. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of 77.94%. Organigram Global, Inc.'s return on equity of -7.06% beat Cronos Group, Inc.'s return on equity of 3.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    0.52% -$0.28 $357.9M
    CRON.TO
    Cronos Group, Inc.
    49.47% $0.09 $1.6B
  • What do Analysts Say About OGI.TO or CRON.TO?

    Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 46.55%. On the other hand Cronos Group, Inc. has an analysts' consensus of $3.95 which suggests that it could grow by 8.52%. Given that Organigram Global, Inc. has higher upside potential than Cronos Group, Inc., analysts believe Organigram Global, Inc. is more attractive than Cronos Group, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    CRON.TO
    Cronos Group, Inc.
    1 1 0
  • Is OGI.TO or CRON.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Cronos Group, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.958%.

  • Which is a Better Dividend Stock OGI.TO or CRON.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cronos Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Cronos Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or CRON.TO?

    Organigram Global, Inc. quarterly revenues are $80.1M, which are larger than Cronos Group, Inc. quarterly revenues of $50.1M. Organigram Global, Inc.'s net income of -$38M is lower than Cronos Group, Inc.'s net income of $39M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Cronos Group, Inc.'s PE ratio is 27.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.15x versus 7.57x for Cronos Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.15x 129.47x $80.1M -$38M
    CRON.TO
    Cronos Group, Inc.
    7.57x 27.70x $50.1M $39M
  • Which has Higher Returns OGI.TO or TSND.TO?

    Terrascend Corp. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of -15.22%. Organigram Global, Inc.'s return on equity of -7.06% beat Terrascend Corp.'s return on equity of -38.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    0.52% -$0.28 $357.9M
    TSND.TO
    Terrascend Corp.
    49.87% -$0.12 $487.1M
  • What do Analysts Say About OGI.TO or TSND.TO?

    Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 46.55%. On the other hand Terrascend Corp. has an analysts' consensus of $1.74 which suggests that it could grow by 79.16%. Given that Terrascend Corp. has higher upside potential than Organigram Global, Inc., analysts believe Terrascend Corp. is more attractive than Organigram Global, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    TSND.TO
    Terrascend Corp.
    4 0 0
  • Is OGI.TO or TSND.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Terrascend Corp. has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.314%.

  • Which is a Better Dividend Stock OGI.TO or TSND.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Terrascend Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Terrascend Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or TSND.TO?

    Organigram Global, Inc. quarterly revenues are $80.1M, which are smaller than Terrascend Corp. quarterly revenues of $89.7M. Organigram Global, Inc.'s net income of -$38M is lower than Terrascend Corp.'s net income of -$13.6M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Terrascend Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.15x versus 0.75x for Terrascend Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.15x 129.47x $80.1M -$38M
    TSND.TO
    Terrascend Corp.
    0.75x -- $89.7M -$13.6M
  • Which has Higher Returns OGI.TO or WEED.TO?

    Canopy Growth Corp. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of -2.46%. Organigram Global, Inc.'s return on equity of -7.06% beat Canopy Growth Corp.'s return on equity of -68.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    0.52% -$0.28 $357.9M
    WEED.TO
    Canopy Growth Corp.
    25.3% -$0.01 $995.3M
  • What do Analysts Say About OGI.TO or WEED.TO?

    Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 46.55%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.76 which suggests that it could grow by 127.88%. Given that Canopy Growth Corp. has higher upside potential than Organigram Global, Inc., analysts believe Canopy Growth Corp. is more attractive than Organigram Global, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    WEED.TO
    Canopy Growth Corp.
    1 4 1
  • Is OGI.TO or WEED.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.

  • Which is a Better Dividend Stock OGI.TO or WEED.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or WEED.TO?

    Organigram Global, Inc. quarterly revenues are $80.1M, which are larger than Canopy Growth Corp. quarterly revenues of $66.7M. Organigram Global, Inc.'s net income of -$38M is lower than Canopy Growth Corp.'s net income of -$1.6M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.15x versus 1.08x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.15x 129.47x $80.1M -$38M
    WEED.TO
    Canopy Growth Corp.
    1.08x -- $66.7M -$1.6M
  • Which has Higher Returns OGI.TO or XLY.TO?

    Auxly Cannabis Group, Inc. has a net margin of -47.42% compared to Organigram Global, Inc.'s net margin of 51.36%. Organigram Global, Inc.'s return on equity of -7.06% beat Auxly Cannabis Group, Inc.'s return on equity of 34.07%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    0.52% -$0.28 $357.9M
    XLY.TO
    Auxly Cannabis Group, Inc.
    22.15% $0.01 $238.5M
  • What do Analysts Say About OGI.TO or XLY.TO?

    Organigram Global, Inc. has a consensus price target of $3.40, signalling upside risk potential of 46.55%. On the other hand Auxly Cannabis Group, Inc. has an analysts' consensus of $0.2500 which suggests that it could grow by 78.57%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Organigram Global, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Organigram Global, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    XLY.TO
    Auxly Cannabis Group, Inc.
    1 0 0
  • Is OGI.TO or XLY.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Auxly Cannabis Group, Inc. has a beta of 1.254, suggesting its more volatile than the S&P 500 by 25.413%.

  • Which is a Better Dividend Stock OGI.TO or XLY.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Auxly Cannabis Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Auxly Cannabis Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or XLY.TO?

    Organigram Global, Inc. quarterly revenues are $80.1M, which are larger than Auxly Cannabis Group, Inc. quarterly revenues of $39.9M. Organigram Global, Inc.'s net income of -$38M is lower than Auxly Cannabis Group, Inc.'s net income of $20.5M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 129.47x while Auxly Cannabis Group, Inc.'s PE ratio is 4.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.15x versus 1.40x for Auxly Cannabis Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.15x 129.47x $80.1M -$38M
    XLY.TO
    Auxly Cannabis Group, Inc.
    1.40x 4.59x $39.9M $20.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
14
SMX alert for Dec 30

SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.

Buy
71
ZCSH alert for Dec 30

Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.

Buy
69
GDXU alert for Dec 30

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock